Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G. Chen

P2.03-09 the Real World of NTRK Fusion Data in the Chinese Lung Cancer Populations: A Multicenter Study

Journal of Thoracic Oncology

English

P3.cr-11 ROS1 Fusion and MET Amplification Dual Drive Coexistence in Lung Adenocarcinoma and Response to Crizotinib: A Case Report

Journal of Thoracic Oncology

English

P1.03-03 Molecular Characteristics of Chinese Patients With TSC2-Mutated Non-Small-Cell Lung Cancer: A Retrospective Study

Journal of Thoracic Oncology

English

OA13.03 Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, Double-Blind Phase 2 Trial

Journal of Thoracic Oncology

English

JCSE01.18 a Multicenter Survey of One Year Survival Among Chinese Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)

Journal of Thoracic Oncology

English

P1.03-32 Molecular Characteristics and Prognosis FBXW7 Mutations in Chinese Non-Small-Cell Lung Cancer Patients

Journal of Thoracic Oncology

English

P2.03-35 Non-Small-Cell Lung Cancer With SMO Gene Variants of Uncertain Significance Share Distinct Molecular Features

Journal of Thoracic Oncology

English

P1.03-04 Molecular Characteristics of ALK Primary Point Mutations Non-Small-Cell Lung Cancer in Chinese Patients

Journal of Thoracic Oncology

English

P3.cr-08 Clonally Related Primary ALK Rearrangement Adenocarcinoma and Associated Metastatic Lesions: A Case Report

Journal of Thoracic Oncology

English

P1.03-23 the Molecular Landscape and Outcome of Chinese Patients With Non-Small Cell Lung Cancer Harboring NTRK1 Point Mutations: A Retrospective Study

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G. Chen

P2.03-09 the Real World of NTRK Fusion Data in the Chinese Lung Cancer Populations: A Multicenter Study

P3.cr-11 ROS1 Fusion and MET Amplification Dual Drive Coexistence in Lung Adenocarcinoma and Response to Crizotinib: A Case Report

P1.03-03 Molecular Characteristics of Chinese Patients With TSC2-Mutated Non-Small-Cell Lung Cancer: A Retrospective Study

OA13.03 Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, Double-Blind Phase 2 Trial

JCSE01.18 a Multicenter Survey of One Year Survival Among Chinese Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)

P1.03-32 Molecular Characteristics and Prognosis FBXW7 Mutations in Chinese Non-Small-Cell Lung Cancer Patients

P2.03-35 Non-Small-Cell Lung Cancer With SMO Gene Variants of Uncertain Significance Share Distinct Molecular Features

P1.03-04 Molecular Characteristics of ALK Primary Point Mutations Non-Small-Cell Lung Cancer in Chinese Patients

P3.cr-08 Clonally Related Primary ALK Rearrangement Adenocarcinoma and Associated Metastatic Lesions: A Case Report

P1.03-23 the Molecular Landscape and Outcome of Chinese Patients With Non-Small Cell Lung Cancer Harboring NTRK1 Point Mutations: A Retrospective Study